Manorama Indust.Q1 FY27
Manorama Indust. Q1 FY27 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹1,912P/E: 46.0Market Cap: ₹12.2K CrSector: Food Products
Management growth scorecard
Revenue
Category 2
Margin
Category 3
Fundraise
Yes
Order
N/A
Capex
Yes
2 of 4 growth signals are positive.
Full analysisRevenue guidance
Category 2- →The company began FY27 on a very healthy note, with Q1 performance establishing a strong run rate for the year.
- →Expectation of healthy top-line growth in FY27 supported by capacity ramp-up and debottlenecking.
- →Focus on improving utilization of plants, targeting around 80%-85% utilization post-debottlenecking.
- →New capex plans include expanding solvent fractionation and refinery capacity, along with backward integration in Burkina Faso, expected to support growth into FY28 and beyond.
- →Additional incremental capacity of approximately 4,500 tons from debottlenecking expected to come online in FY27 Q3, increasing total capacity to around 52,000 tons per annum.
- →Longer-term vision includes steady, healthy growth aligned with strategic investments in India and Africa.
- →Volume growth has significantly contributed to recent revenue growth (e.g., 39% YoY growth largely volume-led).
Margin guidance
Category 3- →The company has demonstrated consistent strong performance over 20-25 quarters, indicating stable growth.
- →Margin improvements are expected directionally upwards over a yearly or 2-year timeframe, supported by multiple operational levers.
- →Operating leverage is anticipated to improve with capacity expansions and better sourcing strategies in the next 2-3 years.
- →Capacity debottlenecking (additional ~4,500 tons) and new capex (INR 460 crores) projected to support steady, healthy growth towards FY30-31.
- →FY27 has started on a healthy note with further margin and top-line growth expected due to capacity ramp-up and better utilization.
- →Other income related to forex gains and FDRs seen as non-recurring, expected to normalize.
- →Profit after tax grew 67.6% YoY in Q1 FY27; EBITDA margin sustained at 26.3% with focus on disciplined cost management.
- →Overall, the company targets sustainable margin and earnings growth with a focus on innovation, efficiency, and global market capture.
3 more insights locked — sign up free to unlock
Fundraise plans
Yes- →The company recently completed a Qualified Institutional Placement (QIP) fundraising of around INR 500 crores through equity dilution in the last quarter.
- →They currently have about INR 150 crores fixed deposits (FDR) with the company excluding the QIP amount.
- →Sanctioned bank limits are in place, with State Bank of India as the lead banker, aligning with near-term vision for capex and working capital.
- →No plans for additional equity dilution in the near term; further working capital requirements over the next 2 years are expected to be met by debt, not equity.
- →The focus is on managing working capital through existing banking relationships and fundraising already completed.
- →The company aims to avoid new equity dilution for at least a quarter or two following the recent QIP.
Order book
The transcript from the provided pages does not mention any specific details about the current or expected order book or pending orders for Manorama Industries Limited. The discussions primarily focus on:
- Capacity expansion and debottlenecking plans.
- Financial performance and margin trajectory.
- Fundraising activities and capex utilization.
- Market diversification and sourcing strategies.
- Operational efficiencies and margin outlook.
No explicit information regarding order backlog or pending order status was provided.
Capex plans
Yes- →Manorama Industries has a proposed capex plan of approximately INR 460 crores, expected to be commissioned by Q3 FY28, with full impact visible in FY29.
- →Capex includes expanding solvent fractionation capacity, refinery capacity in India, and backward integration project in Burkina Faso.
- →Burkina Faso facility capex is around INR 120-130 crores; the balance is for Indian projects.
- →Debottlenecking capacity expansion of 4,500 MTPA during FY27 costing around INR 5-6 crores.
- →Total capex spending planned for FY27 is around INR 225-250 crores, with about INR 70 crores already spent.
- →The Burkina Faso plant aims for a payback period of around 3 years and will reduce freight costs, improving bottom-line efficiency.
- →The capex supports strategic growth in specialty ingredients and enhances sourcing, manufacturing, and value addition capabilities including a new CBA (cocoa butter alternative) plant.
How does Manorama Indust. rank vs peers in Food Products?
Pro feature1Manorama Indust.
Rev 2Mar 3
See full Food Products sector rankings
How does Manorama Indust. rank in Food Products?
Compare Manorama Indust. against every Food Products company (Q1 FY27) on revenue, margins and earnings-call signals.